Need help finding what you are looking for?
Contact Us
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2148322
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2148322
AI in Drug Discovery Market, By Offering, By Technology, By Drug Discovery Process, By Drug Type, By Application, By End User, By Geography
PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
AI in Drug Discovery Market is estimated to be valued at USD 3,240.0 Mn in 2026 and is expected to reach USD 15,536.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 25.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3,240.0 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 25.10% | 2033 Value Projection: | USD 15,536.2 Mn |
Artificial intelligence (AI) is revolutionizing drug discovery in pharmaceutical research by accelerating the identification, development and optimization of novel therapeutic compounds. Researchers are using machine learning, deep learning, natural language processing, and generative AI techniques to analyze complex biological data, predict molecular interactions, identify drug targets, and improve virtual screening and lead optimization.
AI leverages genomic, protein, biomarker and clinical data to generate multidimensional insights that may improve the efficiency and accuracy of drug discovery. The increasing adoption of AI-driven platforms by pharmaceutical companies, biotech firms and research institutes is leading to the creation of more efficient discovery workflows and fueling the expansion of the Global AI in Drug Discovery Market.
Market Dynamics
The global AI in drug discovery market is driven by the escalating cost and complexity of traditional drug discovery, increasing pharmaceutical R&D expenditure, and the mounting volume of genomic, proteomic, and chemical data. AI is accelerating processes such as target identification, virtual screening, lead optimization, and drug property prediction. Furthermore, the increasing collaborations between technology and pharmaceutical companies are fueling the adoption of AI across the drug discovery process.
However, a number of constraints are present in the market, such as standardization issues, data privacy and intellectual property concerns, regulatory uncertainty, and a shortage of professionals with combined AI and life sciences expertise. Nevertheless, significant opportunities exist in generative AI for de novo molecule design, AI-enabled development of therapies for rare diseases, and growing adoption in emerging markets such as Asia-Pacific and Latin America.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global AI in drug discovery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Schrodinger, Inc., Insilico Medicine, Recursion Pharmaceuticals, Inc., Isomorphic Labs Limited, XtalPi Inc., insitro, Inc., BenevolentAI, Generate Biomedicines, Inc., Owkin, Inc., and Atomwise, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global AI in drug discovery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global AI in drug discovery market
Market Segmentation
- Offering Insights (Revenue, USD Mn, 2021 - 2033)
- Software
- Services
- Technology Insights (Revenue, USD Mn, 2021 - 2033)
- Machine Learning
- Deep Learning
- Generative AI
- Natural Language Processing
- Others
- Drug Discovery Process Insights (Revenue, USD Mn, 2021 - 2033)
- Target Identification and Validation
- Hit Identification and Screening
- Lead Identification and Optimization
- Preclinical Development
- Drug Type Insights (Revenue, USD Mn, 2021 - 2033)
- Small-Molecule Drugs
- Large-Molecule Drugs
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Drug Repurposing
- De Novo Drug Design
- Virtual Screening
- Biomarker Discovery
- Others
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic and Research Institutes
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Schrodinger, Inc.
- Insilico Medicine
- Recursion Pharmaceuticals, Inc.
- Isomorphic Labs Limited
- XtalPi Inc.
- insitro, Inc.
- BenevolentAI
- Generate Biomedicines, Inc.
- Owkin, Inc.
- Atomwise, Inc.
Product Code: CMI10138
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global AI in Drug Discovery Market, By Offering
- Global AI in Drug Discovery Market, By Technology
- Global AI in Drug Discovery Market, By Drug Discovery Process
- Global AI in Drug Discovery Market, By Drug Type
- Global AI in Drug Discovery Market, By Application
- Global AI in Drug Discovery Market, By End User
- Global AI in Drug Discovery Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Offering Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Industry Trends
4. Global AI in Drug Discovery Market, By Offering, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global AI in Drug Discovery Market, By Technology, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Machine Learning
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Deep Learning
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Generative AI
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Natural Language Processing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global AI in Drug Discovery Market, By Drug Discovery Process, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Target Identification and Validation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Hit Identification and Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Lead Identification and Optimization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Preclinical Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global AI in Drug Discovery Market, By Drug Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Small-Molecule Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Large-Molecule Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global AI in Drug Discovery Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Drug Repurposing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- De Novo Drug Design
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Virtual Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Biomarker Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global AI in Drug Discovery Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
10. Global AI in Drug Discovery Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Schrodinger, Inc.
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
- Insilico Medicine
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
- Recursion Pharmaceuticals, Inc.
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
- Isomorphic Labs Limited
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
- XtalPi Inc.
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
- insitro, Inc.
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
- BenevolentAI
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
- Generate Biomedicines, Inc.
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
- Owkin, Inc.
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
- Atomwise, Inc.
- Company Highlights
- Offering Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.